Betadine vs Sterile Water for Periurethral Preparation

NCT ID: NCT07044726

Last Updated: 2025-07-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

PHASE4

Total Enrollment

148 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-06-23

Study Completion Date

2028-05-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether cleaning of the urethra, or external opening to the bladder, with sterile water (water that has been treated to remove bacteria and living organisms) vs Betadine also known as Povidone-Iodine (a medical grade cleaning solution) changes the rates of bacteria in the urine after a temporary catheter, or draining tube, is placed into the bladder. Chemical antiseptics, including Betadine, are the current standard of care. An additional goal of this study is to determine whether cleaning of the urethra, or external opening to the bladder, with sterile water vs betadine changes the amount of discomfort or pain patients experience with placement of a temporary catheter, or draining tube, in the bladder.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Catherization Urinary Tract Infection Bacterial

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Betadine

Betadine periurethral preparation

Group Type ACTIVE_COMPARATOR

Povidone-Iodine

Intervention Type DRUG

Providone-Iodine for periurethral preparation

Sterile Water

Sterile Water periurethral preparation

Group Type SHAM_COMPARATOR

Sterile water

Intervention Type DRUG

Sterile water for periurethral preparation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Povidone-Iodine

Providone-Iodine for periurethral preparation

Intervention Type DRUG

Sterile water

Sterile water for periurethral preparation

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 18+
* Patient undergoing in office straight catherization

Exclusion Criteria

* History of culture proven recurrent urinary tract infection (2 in any 6-month period or 3 in any 12-month period)
* Urine Analysis with +Nitrites
* Catherization for any reason in the last 4 weeks
* History of Iodine allergy
* Patients unable to speak English
* Patient does not have the capacity to consent
* 2-3rd trimester pregnancy
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Louisville

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ankita Gupta

Associate Fellowship Director of Urogynecology and Pelvic Reconstructive Surgery

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ankita Gupta, MD, MPH

Role: PRINCIPAL_INVESTIGATOR

University of Louisville

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UofL Physicians - Urogynecology Springs Urogynecology Office

Louisville, Kentucky, United States

Site Status

UofL Health - Urogynecology Mary & Elizabeth Hospital, Medical Plaza 4

Louisville, Kentucky, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Kathryn C Seymour, MD

Role: CONTACT

502-588-7660

Ankita Gupta, MD, MPH

Role: CONTACT

502-588-7660

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Kathryn Seymour, MD

Role: primary

502-588-7660

Kathryn Seymour, MD

Role: primary

502-588-7660

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

25.0260

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effect of Chlorhexidine on Bacteriuria
NCT02032394 UNKNOWN PHASE4